Company Search:
Advanced Search
Sponsored Links
Kainos Laboratories, Inc. Company Snapshot
Kainos Laboratories, Inc. operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kainos Laboratories with three other pharmaceutical manufacturers in Asia: Mangalam Drugs & Organics Limited of India (2018 sales of 2.79 billion Indian Rupees [US$38.64 million] ), Albert David Limited of India (2.87 billion Indian Rupees [US$39.75 million] ), and Ind-Swift Limited which is also based in India (2.71 billion Indian Rupees [US$37.42 million] ).

Sales Analysis. During the year ended March of 2018, sales at Kainos Laboratories were ¥4.39 billion (US$38.69 million). This is a decrease of 6.7% versus 2017, when the company's sales were ¥4.70 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kainos Laboratories, Inc.
  Stock Performance Chart for Kainos Laboratories, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 933.00
(Figures in Japanese Yen)
1 Week -5.3%   13 Weeks -14.2%  
4 Weeks 0.8%   52 Weeks 33.5%  
Kainos Laboratories, Inc. Key Data:
  Ticker: 4556 Country: Japan
  Exchanges: TYO OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2018 Sales 4,386,699,000
(Year Ending Jan 2019).
Employees: 158
  Currency: Japanese Yen Market Cap: 3,442,068,384
  Fiscal Yr Ends: March Shares Outstanding: 3,689,248
  Share Type: Common Closely Held Shares: 1,390,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.